+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Prostate Cancer Treatment Device Market Research Report: By Type (Radiation, Surgery, High-Intensity Focused Ultrasound, Cryotherapy), End User (Hospitals, Specialty Centers) - Industry Analysis and Growth Forecast to 2030

  • ID: 5201164
  • Report
  • September 2020
  • Region: United States
  • 124 pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • Accuray Incorporated
  • Eckert & Ziegler AG
  • EDAP TMS SA
  • Elekta AB
  • HealthTronics Inc.
  • Intuitive Surgical Inc.
  • MORE
The U.S. prostate cancer treatment devices market attained a value of $95.9 million in 2019 and is predicted to grow at a CAGR of 5.6% between 2020 and 2030. According to the forecast the publisher, a market research firm based in India, the market would reach a valuation of $157.1 million by 2030. The main factors driving the progress of the market are the increasing number of prostate cancer cases being recorded in the country every year.

The high prevalence of this diseases is predicted to push up the demand for various treatment devices and equipment such as cryotherapy, surgery, and radiotherapy in the future years, thereby causing the expansion of the U.S. prostate cancer treatment devices market. Apart from this, the increasing number of government initiatives being implemented in the country is also fueling the market advancement. The federal government spends a huge portion of the country’s GDP on healthcare every year.

As per the reports of the National Health Expenditure Accounts (NHEA), healthcare expenditure in the U.S. increased by as much as 4.3% and reached $3.3 trillion in 2016. This percentage further grew to 5.4% in 2017. The soaring healthcare expenditure is making the management and treatment of various diseases more affordable than they were before, which is, in turn, fueling the expansion of the U.S. prostate cancer treatment devices market.

Thus, it can be said with certainty that the market would demonstrate substantial growth in the upcoming years, mainly because of the rising incidence of prostate cancer and the surging government spending on healthcare in the country.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accuray Incorporated
  • Eckert & Ziegler AG
  • EDAP TMS SA
  • Elekta AB
  • HealthTronics Inc.
  • Intuitive Surgical Inc.
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by End User
1.3.3 Market Segmentation by State
1.3.4 Analysis Period
1.3.5 Market Data Reporting Unit
1.3.5.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Split of Primary Research Information
2.2.2 Breakdown of Primary Research by Industry Participant
2.2.3 Breakdown of Primary Research by company type
2.2.4 Breakdown of Primary Research by Company and Designation
2.3 Baseline Methodology
2.4 Market Size Estimation
2.5 Data Triangulation
2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 Radiation
4.1.1.1.1 Clinical trials
4.1.1.2 Surgery
4.1.1.2.1 Clinical trials
4.1.1.3 HIFU
4.1.1.3.1 Clinical trials
4.1.1.4 Cryotherapy
4.1.1.4.1 Clinical trials
4.1.1.5 Others
4.1.2 By End User
4.1.2.1 Hospitals
4.1.2.2 Specialty centers
4.1.2.3 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Adoption of robotic prostatectomy
4.2.1.2 Accelerating evolution in radiotherapy techniques
4.2.2 Drivers
4.2.2.1 Technological advancements
4.2.2.2 Increasing prevalence of prostate cancer
4.2.2.3 Rising number of government initiatives
4.2.2.4 Surging geriatric population
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Longer approval time for prostate cancer devices
4.2.3.2 Challenges in identifying molecular predictors of response to radiotherapy
4.2.3.3 Impact analysis of drivers on market forecast
4.2.4 Opportunities
4.2.4.1 Positioning devices to improve treatment and patient experience
4.3 COVID-19 Impact on U.S. Prostate Cancer Treatment Devices Market
4.3.1 Supply Side Analysis
4.3.2 Demand Side Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Buyers
4.4.2 Bargaining Power of Suppliers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes
4.5 Therapy Comparison
4.5.1 HIFU Therapy
4.5.2 Surgery Vs Radiation Therapy
4.5.3 Cryotherapy
4.6 Average Pricing of Devices

Chapter 5. U.S. Market Size and Forecast
5.1 By Type
5.2 By End User
5.3 By State

Chapter 6. Competitive Landscape
6.1 Product Benchmarking of Key Players
6.2 Strategic Developments of Key Players
6.2.1 Approvals and Product Launch
6.2.2 Mergers and Acquisitions
6.2.3 Other Developments

Chapter 7. Company Profiles
7.1 SonaCare Medical LLC
7.1.1 Business Overview
7.1.2 Product and Service Offerings
7.2 EDAP TMS SA
7.2.1 Business Overview
7.2.2 Product and Service Offerings
7.2.3 Key Financial Summary
7.3 Profound Medical Corporation
7.3.1 Business Overview
7.3.2 Product and Service Offerings
7.3.3 Key Financial Summary
7.4 Eckert & Ziegler AG
7.4.1 Business Overview
7.4.2 Product and Service Offerings
7.4.3 Key Financial Summary
7.5 HealthTronics Inc.
7.5.1 Business Overview
7.5.2 Product and Service Offerings
7.6 Boston Scientific Corporation
7.6.1 Business Overview
7.6.2 Product and Service Offerings
7.6.3 Key Financial Summary
7.7 Elekta AB
7.7.1 Business Overview
7.7.2 Product and Service Offerings
7.7.3 Key Financial Summary
7.8 Accuray Incorporated
7.8.1 Business Overview
7.8.2 Product and Service Offerings
7.8.3 Key Financial Summary
7.9 Varian Medical Systems Inc.
7.9.1 Business Overview
7.9.2 Product and Service Offerings
7.9.3 Key Financial Summary
7.10 Becton, Dickinson and Company
7.10.1 Business Overview
7.10.2 Product and Service Offerings
7.10.3 Key Financial Summary
7.11 Intuitive Surgical Inc.
7.11.1 Business Overview
7.11.2 Product and Service Offerings
7.11.3 Key Financial Summary
7.12 ViewRay Inc.
7.12.1 Business Overview
7.12.2 Product and Service Offerings
7.12.3 Key Financial Summary
7.13 Provision Healthcare
7.13.1 Business Overview
7.13.2 Product and Service Offerings
7.14 Isoray Inc.
7.14.1 Business Overview
7.14.2 Product and Service Offerings
7.14.3 Key Financial Summary
7.15 Theragenics Corporation
7.15.1 Business Overview
7.15.2 Product and Service Offerings

Chapter 8. Appendix
8.1 Abbreviations
8.2 Sources and References
8.3 Related Reports

List of Tables
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 RADIATION - CLINICAL TRIAL - 1
TABLE 3 RADIATION - CLINICAL TRIAL - 2
TABLE 4 RADIATION - CLINICAL TRIAL - 3
TABLE 5 RADIATION - CLINICAL TRIAL - 4
TABLE 6 RADIATION - CLINICAL TRIAL - 5
TABLE 7 RADIATION - CLINICAL TRIAL - 6
TABLE 8 RADIATION - CLINICAL TRIAL - 7
TABLE 9 RADIATION - CLINICAL TRIAL - 8
TABLE 10 SURGERY - CLINICAL TRIAL - 1
TABLE 11 SURGERY - CLINICAL TRIAL - 2
TABLE 12 SURGERY - CLINICAL TRIAL - 3
TABLE 13 SURGERY - CLINICAL TRIAL - 4
TABLE 14 SURGERY - CLINICAL TRIAL - 5
TABLE 15 SURGERY - CLINICAL TRIAL - 6
TABLE 16 SURGERY - CLINICAL TRIAL - 7
TABLE 17 HIFU - CLINICAL TRIAL - 1
TABLE 18 HIFU - CLINICAL TRIAL - 2
TABLE 19 HIFU - CLINICAL TRIAL - 3
TABLE 20 HIFU - CLINICAL TRIAL - 4
TABLE 21 HIFU - CLINICAL TRIAL - 5
TABLE 22 HIFU - CLINICAL TRIAL - 6
TABLE 23 HIFU - CLINICAL TRIAL - 7
TABLE 24 CRYOTHERAPY - CLINICAL TRIAL - 1
TABLE 25 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 26 RESTRAINT FOR THE MARKET: IMPACT ANALYSIS
TABLE 27 HIFU - SONABLATE VS AMBLATHERM (SYSTEM SPECIFICATION)
TABLE 28 HIFU - SONABLATE VS AMBLATHERM (SAFETY FEATURE)
TABLE 29 PREFERECE OF TREATMENT - SURGERY VS RADIATION THERAPY
TABLE 30 PROCESS OF TREATMENT - SURGERY VS RADIATION THERAPY
TABLE 31 BENEFITS OF TREATMENT- SURGERY VS RADIATION THERAPY
TABLE 32 SIDE-EFFECTS AND DRAWBACKS OF TREATMENT- SURGERY VS RADIATION THERAPY
TABLE 33 AVERAGE PRICING OF DEVICES
TABLE 34 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY TYPE, UNITS (2014-2019)
TABLE 35 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY TYPE, UNITS (2020-2030)
TABLE 36 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY TYPE, $M (2014-2019)
TABLE 37 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY TYPE, $M (2020-2030)
TABLE 38 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY END USER, $M (2014-2019)
TABLE 39 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY END USER, $M (2020-2030)
TABLE 40 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY STATE, $M (2014-2019)
TABLE 41 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY STATE, $M (2020-2030)
TABLE 42 SONACARE MEDICAL LLC - AT A GLANCE
TABLE 43 EDAP TMS SA - AT A GLANCE
TABLE 44 EDAP TMS SA - KEY FINANCIAL SUMMARY
TABLE 45 PROFOUND MEDICAL CORPORATION - AT A GLANCE
TABLE 46 PROFOUND MEDICAL CORPORATION - KEY FINANCIAL SUMMARY
TABLE 47 ECKERT & ZIEGLER AG - AT A GLANCE
TABLE 48 ECKERT & ZIEGLER AG - KEY FINANCIAL SUMMARY
TABLE 49 HEALTHTRONICS INC. - AT A GLANCE
TABLE 50 BOSTON SCIENTIFIC CORPORATION - AT A GLANCE
TABLE 51 BOSTON SCIENTIFIC CORPORATION - KEY FINANCIAL SUMMARY
TABLE 52 ELEKTA AB - AT A GLANCE
TABLE 53 ELEKTA AB - KEY FINANCIAL SUMMARY
TABLE 54 ACCURAY INCORPORATED - AT A GLANCE
TABLE 55 ACCURAY INCORPORATED - KEY FINANCIAL SUMMARY
TABLE 56 VARIAN MEDICAL SYSTEMS INC. - AT A GLANCE
TABLE 57 VARIAN MEDICAL SYSTEMS INC. - KEY FINANCIAL SUMMARY
TABLE 58 BECTON, DICKINSON AND COMPANY - AT A GLANCE
TABLE 59 BECTON, DICKINSON AND COMPANY - KEY FINANCIAL SUMMARY
TABLE 60 INTUITIVE SURGICAL INC. - AT A GLANCE
TABLE 61 INTUITIVE SURGICAL INC. - KEY FINANCIAL SUMMARY
TABLE 62 VIEWRAY INC. - AT A GLANCE
TABLE 63 VIEWRAY INC. - KEY FINANCIAL SUMMARY
TABLE 64 PROVISION HEALTHCARE - AT A GLANCE
TABLE 65 ISORAY INC. - AT A GLANCE
TABLE 66 ISORAY INC. - KEY FINANCIAL SUMMARY
TABLE 67 THERAGENICS CORPORATION - AT A GLANCE

List of Figures
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 SPLIT OF PRIMARY INFORMATION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 SPLIT OF PRIMARY RESEARCH BY COMPANY AND DESIGNATION
FIG 8 DATA TRIANGULATION APPROACH
FIG 9 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET SUMMARY
FIG 10 BARGAINING POWER OF BUYERS
FIG 11 BARGAINING POWER OF SUPPLIERS
FIG 12 INTENSITY OF RIVALRY
FIG 13 THREAT OF NEW ENTRANTS
FIG 14 THREAT OF SUBSTITUTES
FIG 15 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET SNAPSHOT
FIG 16 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, SHARE & $M (2019)
FIG 17 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY TYPE, UNITS (2014-2030)
FIG 18 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY TYPE, $M (2014-2030)
FIG 19 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY END USER, $M (2014-2030)
FIG 20 U.S. PROSTATE CANCER TREATMENT DEVICES MARKET, BY STATE, $M (2014-2030)
FIG 21 PRODUCT BENCHMARKING OF KEY PLAYERS
FIG 22 EDAP TMS SA - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 23 PROFOUND MEDICAL CORPORATION - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 24 ECKERT & ZIEGLER AG - REVENUE SPLIT BY SEGMENT AND BY GEOGRAPHY (2019)
FIG 25 BOSTON SCIENTIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 26 ELEKTA AB - REVENUE SPLIT BY GEOGRAPHY (2020)
FIG 27 ACCURAY INCOPORATED - REVENUE SPLIT BY GEOGRAPHY (2020)
FIG 28 VARIAN MEDICAL SYSTEMS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 29 BECTON, DICKINSON AND COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 30 INTUITIVE SURGICAL INC. - REVENUE SPLIT PRODUCT AND SERVICE AND GEOGRAPHY (2019)
FIG 31 VIEWRAY INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
FIG 32 ISORAY INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
Note: Product cover images may vary from those shown
  • SonaCare Medical LLC
  • EDAP TMS SA
  • Profound Medical Corporation
  • Eckert & Ziegler AG
  • HealthTronics Inc.
  • Boston Scientific Corporation
  • Elekta AB
  • Accuray Incorporated
  • Varian Medical Systems Inc.
  • Becton, Dickinson and Company
  • Intuitive Surgical Inc.
  • ViewRay Inc.
  • Provision Healthcare
  • Isoray Inc.
  • Theragenics Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll